GARAGIOLA, ISABELLA MARIA

GARAGIOLA, ISABELLA MARIA  

Dipartimento di Fisiopatologia Medico-Chirurgica e dei Trapianti  

Mostra records
Risultati 1 - 20 di 80 (tempo di esecuzione: 0.0 secondi).
Titolo Data di pubblicazione Autori Tipo File Abstract
Gender equity in hemophilia: need for healthcare, familial, and societal advocacy 2024 Gualtierotti, RobertaGaragiola, IsabellaMortarino, MimosaSpena, SilviaPeyvandi, Flora + Article (author) -
Exploring nonreplacement therapies’ impact on hemophilia and other rare bleeding disorders 2024 Peyvandi, FloraSeidizadeh, OmidMohsenian, SaminGaragiola, Isabella Article (author) -
Knowledge and attitudes toward gene therapy of a cohort of Italian patients with hemophilia 2023 Cutica, IlariaMortarino, MimosaGaragiola, IsabellaPravettoni, GabriellaPeyvandi, Flora Article (author) -
Psychological and cognitive factors involved in decision‐making process of haemophilia carriers in reproductive choices 2023 Ilaria CuticaMimosa MortarinoIsabella GaragiolaGabriella PravettoniFlora Peyvandi Article (author) -
Fitusiran in haemophilia: a breakthrough drug with many unknowns 2023 Peyvandi, FloraGaragiola, IsabellaAbbattista, Maria Article (author) -
Updates on Novel Non-Replacement Drugs for Hemophilia 2022 Gualtierotti R.Ciavarella A.Arcudi S.Giachi A.Garagiola I.Suffritti C.Siboni S. M.Peyvandi F. + Article (author) -
Genetic variants at the chromosomal region 2q21.3 underlying inhibitor development in patients with severe haemophilia A 2022 Spena S.Pappalardo E.Gorski M. M.Garagiola I.Hassan S.Gualtierotti R.Peyvandi F. + Article (author) -
The EHA research roadmap: Blood coagulation and hemostatic disorders 2021 Cattaneo M.Garagiola I.Peyvandi F. + Article (author) -
Immune Responses to Plasma-Derived Versus Recombinant FVIII Products 2021 Peyvandi F.Miri S.Garagiola I. Article (author) -
Development of a specific monoclonal antibody to detect male cells expressing the rps4y1 protein 2021 Spena S.Garagiola I.Peyvandi F. + Article (author) -
Post-authorization pharmacovigilance for hemophilia in Europe and the USA: Independence and transparency are keys 2021 Peyvandi F.Garagiola I.Mannucci P. M. Article (author) -
Performance of a clinical risk prediction model for inhibitor formation in severe haemophilia A 2021 Hassan S.Palla R.Valsecchi C.Garagiola I.Karimi M.Mannucci P. M.Peyvandi F. + Article (author) -
X Chromosome inactivation: a modifier of factor VIII and IX plasma levels and bleeding phenotype in Haemophilia carriers 2020 Garagiola I.Mortarino M.Siboni S. M.Mancuso M. E.Biganzoli M.Peyvandi F. + Article (author) -
Molecular Aggregation of Marketed Recombinant FVIII Products: Biochemical Evidence and Functional Effects 2019 Garagiola, IsabellaValsecchi, CarlaPeyvandi, Flora + Article (author) -
Clinical advances in gene therapy updates on clinical trials of gene therapy in haemophilia 2019 Peyvandi F.Garagiola I. Article (author) -
Real-life experience in switching to new extended half-life products at European haemophilia centres 2019 Peyvandi F.Garagiola I. + Article (author) -
Prediction of Factor VIII inhibitor development in the SIPPET cohort by mutational analysis and Factor VIII antigen measurement 2018 S. SpenaI. GaragiolaP. M. MannucciF. Payvandi + Article (author) -
Product type and other environmental risk factors for inhibitor development in severe hemophilia A 2018 Peyvandi, FloraGaragiola, Isabella Article (author) -
Risk factors for inhibitor development in severe hemophilia A 2018 Garagiola, IsabellaPalla, RobertaPeyvandi, Flora Article (author) -
Timing and severity of inhibitor development in recombinant versus plasma-derived factor VIII concentrates: a SIPPET analysis 2018 Peyvandi, F.Garagiola, I.Palla, R.Karimi, M. + Article (author) -